Results 51 to 60 of about 996 (222)

A possible impact lull in the middle of the Eratosthenian period suggested by the Chang’e-5 and 6 missions

open access: yesAstronomy & Astrophysics
Context. It was generally believed that lunar impact flux over the past 3.5 billion years has been almost constant. However, there are still considerable age gaps, causing the evolution of impact flux to remain elusive.
Xie Minggang, Li Yan
doaj   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Latest Scientific Results of China’s Lunar and Deep Space Exploration (2022–2024)

open access: yesKongjian kexue xuebao
China has successfully launched six lunar probes so far. From Chang’E-1 to Chang’E-4, they completed the circling, landing and roving exploration, of which Chang’E-4 was the first landing on the far side of the Moon in human history.
XU Lin   +10 more
doaj   +1 more source

50 Years of Luna legacy [PDF]

open access: yes, 2022
50 years since the USSR's Luna 16, 20 and 24 missions gifted the world an important set of Moon rock samples. Samantha Bell, Katherine Joy and Keith Moore discuss the efforts of UK researchers and how the sample are to be ...
Bell, Samantha   +2 more
core   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

The Geological History of the Chang’e-5 Sample Return Region

open access: yesRemote Sensing, 2021
Chang’e-5 (CE-5), China’s first sample-return mission, has successfully landed in Oceanus Procellarum near Mons Rümker. It is important to have a detailed study of the geological evolution of the CE-5 sample return region.
Jiayin Deng   +5 more
doaj   +1 more source

Two episodes of lunar basaltic volcanism in mare fecunditatis as revealed by LUNA-16 soil samples [PDF]

open access: yes
Two types of mare basalt have been previously reported in the Luna-16 returned soil samples: dominant Intermediate-Ti basalts and minor Very-Low-Ti (VLT) basalts.
Ban, Yiyi   +21 more
core   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy